TEVA PHARMACEUTICAL INDUSTRIES LIMITED Long-Term Debt, Maturity, Year Four
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Long-Term Debt, Maturity, Year Four of $2.44 billion as of 2024-12-31, per its 10-K filed 2025-02-05.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2025-02-05
- 2024-12-31: Long-Term Debt, Maturity, Year Four $2.44B.
- 2023-12-31: Long-Term Debt, Maturity, Year Four $2.08B.
- 2022-12-31: Long-Term Debt, Maturity, Year Four $2.93B.
- 2021-12-31: Long-Term Debt, Maturity, Year Four $3.52B.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2024-12-31 | $2.44B 10-K · filed 2025-02-05 |
| 2023-12-31 | $2.08B 10-K · filed 2024-02-12 |
| 2022-12-31 | $2.93B 10-K · filed 2023-02-10 |
| 2021-12-31 | $3.52B 10-K · filed 2022-02-09 |
| 2020-12-31 | $3.09B 10-K · filed 2021-02-10 |
| 2019-12-31 | $2.92B 10-K · filed 2020-02-21 |
| 2018-12-31 | $4.47B 10-K · filed 2019-02-19 |
| 2017-12-31 | $4.21B 10-K · filed 2018-02-12 |
| 2016-12-31 | $4.03B 20-F · filed 2017-02-15 |
| 2015-12-31 | $1.38B 20-F · filed 2016-02-11 |
| 2014-12-31 | $779.00M 20-F · filed 2015-02-09 |
| 2013-12-31 | $648.00M 20-F · filed 2014-02-10 |
| 2012-12-31 | $1.49B 20-F · filed 2013-02-12 |
| 2011-12-31 | $1.52B 20-F · filed 2012-02-17 |
| 2010-12-31 | $9.00M 20-F · filed 2011-02-15 |